URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Michael Keefer

Concepts (246)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
AIDS Vaccines
44
1992
67
5.640
Why?
HIV-1
38
1992
544
3.470
Why?
HIV Infections
25
1993
600
1.990
Why?
HIV Envelope Protein gp120
22
1993
46
1.880
Why?
HIV Antibodies
24
1992
48
1.590
Why?
Genetic Vectors
9
1999
328
1.160
Why?
Vaccinia virus
9
1992
53
1.080
Why?
Vaccines, Synthetic
21
1991
89
1.060
Why?
Gene Products, env
9
1991
14
1.040
Why?
T-Lymphocytes, Cytotoxic
12
1996
130
0.820
Why?
Fowlpox virus
1
2011
1
0.750
Why?
Drug Carriers
1
2011
21
0.740
Why?
Double-Blind Method
27
1989
985
0.720
Why?
Protein Precursors
8
1991
82
0.700
Why?
Canarypox virus
4
2003
4
0.640
Why?
Immunization, Secondary
12
1992
68
0.630
Why?
CD8-Positive T-Lymphocytes
10
1997
223
0.630
Why?
Adult
44
1989
10906
0.600
Why?
Adjuvants, Immunologic
8
1993
118
0.570
Why?
Adolescent
25
1989
4513
0.560
Why?
Vaccination
8
1992
197
0.550
Why?
Immunization
6
1996
153
0.490
Why?
Middle Aged
35
1989
9461
0.450
Why?
Female
38
1991
19061
0.440
Why?
CD4-Positive T-Lymphocytes
9
1992
299
0.410
Why?
Pericarditis, Constrictive
1
2002
4
0.400
Why?
Male
35
1991
18870
0.400
Why?
Humans
55
1986
35000
0.400
Why?
Peptide Fragments
9
1993
277
0.400
Why?
Immunocompetence
1
2002
30
0.390
Why?
Candida
1
2002
23
0.390
Why?
Young Adult
9
2008
1013
0.390
Why?
Candidiasis
1
2002
36
0.390
Why?
Neutralization Tests
15
1993
128
0.380
Why?
Avipoxvirus
4
1998
4
0.380
Why?
Antibodies, Neutralizing
2
2010
31
0.360
Why?
HIV Seronegativity
8
1994
21
0.350
Why?
HIV Envelope Protein gp160
10
1991
15
0.330
Why?
Interferon-gamma
7
1993
340
0.330
Why?
Recombinant Proteins
11
1993
706
0.320
Why?
Adenoviridae
4
2007
121
0.290
Why?
Immunity, Cellular
7
1991
135
0.290
Why?
Squalene
1
1996
3
0.270
Why?
Polysorbates
1
1996
9
0.270
Why?
Herpesvirus 1, Human
2
2006
63
0.270
Why?
Vaccines, Subunit
4
2003
11
0.270
Why?
T-Lymphocytes
6
1993
546
0.260
Why?
Leukocytes, Mononuclear
3
1991
109
0.260
Why?
Epitopes
4
1986
200
0.250
Why?
Amino Acid Sequence
9
1993
1198
0.250
Why?
Viral Vaccines
3
1991
107
0.250
Why?
Dose-Response Relationship, Immunologic
6
1994
60
0.250
Why?
Human Immunodeficiency Virus Proteins
2
2010
2
0.240
Why?
Time Factors
8
1989
3047
0.240
Why?
Vaccines, DNA
2
2009
22
0.230
Why?
Lymphocyte Activation
10
1992
407
0.230
Why?
Enzyme-Linked Immunosorbent Assay
9
1993
459
0.230
Why?
Antibody Specificity
3
1986
104
0.220
Why?
Genes, gag
2
2006
7
0.210
Why?
DNA, Viral
3
1997
288
0.200
Why?
Antibodies, Anti-Idiotypic
1
2012
54
0.200
Why?
Autoantibodies
1
2012
109
0.190
Why?
Molecular Sequence Data
8
1993
1993
0.190
Why?
Spectinomycin
1
1991
6
0.190
Why?
Urethritis
1
1991
11
0.190
Why?
Antigens, Viral
3
2004
151
0.190
Why?
Chlamydia Infections
1
1991
22
0.190
Why?
Placebos
5
1989
177
0.180
Why?
Gene Products, gag
2
2006
17
0.180
Why?
Mannitol
1
2010
32
0.180
Why?
Oleic Acids
1
2010
15
0.180
Why?
Safety
7
1993
99
0.180
Why?
Follow-Up Studies
4
1994
1757
0.180
Why?
Anti-Infective Agents
1
1991
74
0.180
Why?
Antibodies, Viral
6
1992
472
0.180
Why?
Immune Evasion
1
2010
4
0.180
Why?
Abscess
1
2010
48
0.180
Why?
Adenoviridae Infections
1
2010
10
0.170
Why?
Simian immunodeficiency virus
1
2010
30
0.170
Why?
Models, Immunological
1
2010
62
0.170
Why?
CD4 Lymphocyte Count
4
1997
147
0.170
Why?
HIV-2
1
2009
4
0.170
Why?
Antifungal Agents
2
1997
61
0.160
Why?
Epitopes, T-Lymphocyte
1
2009
32
0.160
Why?
Acquired Immunodeficiency Syndrome
3
1992
207
0.160
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2008
79
0.160
Why?
Peptides
1
2010
277
0.150
Why?
National Institutes of Health (U.S.)
3
1994
60
0.150
Why?
Risk-Taking
3
1998
73
0.150
Why?
Treatment Outcome
4
1997
2487
0.140
Why?
Cytokines
4
1998
555
0.140
Why?
Gene Expression Regulation, Viral
1
2006
33
0.140
Why?
Viral Load
3
1997
138
0.130
Why?
Immunization Schedule
6
1996
43
0.130
Why?
Staining and Labeling
1
2005
161
0.120
Why?
Rabies Vaccines
1
2004
6
0.120
Why?
Viral Proteins
1
2005
216
0.110
Why?
Promoter Regions, Genetic
1
2006
534
0.110
Why?
Viral Envelope Proteins
1
2004
90
0.110
Why?
Clinical Trials, Phase II as Topic
2
1998
13
0.110
Why?
Hispanic Americans
1
2004
86
0.110
Why?
Data Interpretation, Statistical
1
2004
154
0.110
Why?
African Continental Ancestry Group
1
2004
116
0.110
Why?
Sex Characteristics
1
2004
138
0.110
Why?
Pregnancy
3
1994
1919
0.100
Why?
Glycoproteins
1
2004
189
0.100
Why?
Pericardiectomy
1
2002
2
0.100
Why?
European Continental Ancestry Group
1
2004
225
0.100
Why?
env Gene Products, Human Immunodeficiency Virus
2
2011
13
0.100
Why?
HIV Antigens
2
1998
11
0.100
Why?
Rare Diseases
1
2002
27
0.100
Why?
Antibody-Dependent Cell Cytotoxicity
2
1998
28
0.100
Why?
Cells, Cultured
5
1993
2367
0.100
Why?
Saponins
1
2001
6
0.090
Why?
United States
3
1994
2511
0.090
Why?
HIV Seropositivity
2
1994
32
0.090
Why?
T-Lymphocytes, Regulatory
1
2001
48
0.090
Why?
Combined Modality Therapy
1
2002
459
0.090
Why?
Infectious Disease Transmission, Vertical
1
1999
45
0.080
Why?
Voluntary Workers
1
1998
6
0.080
Why?
Immunity, Active
2
1994
9
0.080
Why?
AIDS Serodiagnosis
1
1998
11
0.080
Why?
Pregnancy Complications, Infectious
1
1999
82
0.080
Why?
Prejudice
1
1998
46
0.080
Why?
Itraconazole
1
1997
6
0.070
Why?
Histoplasmosis
1
1997
9
0.070
Why?
Antibody Formation
3
1994
176
0.070
Why?
Th1 Cells
1
1998
72
0.070
Why?
Risk Assessment
1
2002
808
0.070
Why?
AIDS-Related Opportunistic Infections
1
1997
54
0.070
Why?
Th2 Cells
1
1998
89
0.070
Why?
Patient Participation
1
1997
71
0.070
Why?
Consumer Product Safety
1
1996
4
0.070
Why?
Immunotherapy
1
1997
88
0.070
Why?
Pregnancy Outcome
1
1997
136
0.070
Why?
Blotting, Western
3
1991
617
0.060
Why?
Mice, Inbred BALB C
2
2006
616
0.060
Why?
Influenza Vaccines
1
1998
239
0.060
Why?
Flow Cytometry
2
2005
597
0.060
Why?
Immunoenzyme Techniques
1
1994
220
0.060
Why?
Research
1
1994
169
0.060
Why?
Cytotoxicity, Immunologic
1
1993
116
0.050
Why?
Animals
6
1986
15647
0.050
Why?
Cohort Studies
2
1994
912
0.050
Why?
Immunophenotyping
1
2012
123
0.050
Why?
pol Gene Products, Human Immunodeficiency Virus
1
2011
2
0.050
Why?
nef Gene Products, Human Immunodeficiency Virus
1
2011
2
0.050
Why?
gag Gene Products, Human Immunodeficiency Virus
1
2011
6
0.050
Why?
Cross Reactions
2
1986
110
0.050
Why?
Aluminum Hydroxide
2
2001
13
0.050
Why?
Immune Tolerance
1
2012
145
0.050
Why?
Injections, Intramuscular
1
1991
70
0.050
Why?
Drug Evaluation
1
1991
98
0.050
Why?
Neoplasms
1
1997
701
0.050
Why?
Anemia
1
2011
76
0.050
Why?
Freund's Adjuvant
1
2010
6
0.050
Why?
Hypersensitivity, Delayed
2
2000
52
0.050
Why?
Prospective Studies
3
1997
1606
0.040
Why?
Founder Effect
1
2010
6
0.040
Why?
Vaccines, Combined
2
1998
18
0.040
Why?
Simian Acquired Immunodeficiency Syndrome
1
2010
17
0.040
Why?
Macaca
1
2010
69
0.040
Why?
RNA, Viral
2
1997
274
0.040
Why?
Amantadine
1
1989
22
0.040
Why?
Immunoglobulin G
1
2011
491
0.040
Why?
Models, Theoretical
1
2010
190
0.040
Why?
Cell Division
1
1991
735
0.040
Why?
Sequence Alignment
1
2009
197
0.040
Why?
Genes, env
1
2007
9
0.040
Why?
B-Lymphocytes
1
2012
460
0.040
Why?
Mice
3
1986
5900
0.040
Why?
Chromium
1
2007
4
0.040
Why?
Acute Disease
1
2009
570
0.040
Why?
3T3 Cells
1
2006
69
0.030
Why?
Aged
3
1993
6986
0.030
Why?
Antibody Affinity
2
1994
13
0.030
Why?
Employment
2
1994
62
0.030
Why?
Factor V
1
1986
19
0.030
Why?
DNA Primers
1
2007
401
0.030
Why?
Plasmids
1
2007
362
0.030
Why?
Megakaryocytes
1
1986
66
0.030
Why?
Influenza, Human
1
1989
329
0.030
Why?
Dendritic Cells
1
2006
110
0.030
Why?
Lymphocytes
2
1993
293
0.030
Why?
Mucous Membrane
1
2004
37
0.030
Why?
Salmonella
1
2003
7
0.030
Why?
Clinical Trials, Phase I as Topic
1
2003
11
0.030
Why?
Time
1
2003
44
0.030
Why?
Leukocyte Count
2
1992
152
0.030
Why?
Base Sequence
1
2007
1681
0.030
Why?
Transcription, Genetic
1
2006
795
0.030
Why?
Cell Line
1
2006
1554
0.030
Why?
Immunity, Mucosal
1
2001
25
0.020
Why?
Microspheres
1
2001
53
0.020
Why?
Vaccines, Attenuated
1
2001
82
0.020
Why?
Clinical Trials as Topic
1
2005
664
0.020
Why?
HIV Protease
1
2001
22
0.020
Why?
Antibody-Producing Cells
1
2001
37
0.020
Why?
Randomized Controlled Trials as Topic
1
2003
400
0.020
Why?
Administration, Oral
1
2001
302
0.020
Why?
CHO Cells
1
2001
180
0.020
Why?
Cricetinae
1
2001
361
0.020
Why?
Retroviridae Proteins
1
1999
11
0.020
Why?
Genes, Viral
1
1999
88
0.020
Why?
Dose-Response Relationship, Drug
2
1989
1085
0.020
Why?
False Positive Reactions
1
1998
81
0.020
Why?
Virus Replication
2
1989
287
0.020
Why?
Rabies virus
1
1998
4
0.020
Why?
Insurance, Health
1
1998
77
0.020
Why?
Antibodies, Blocking
1
1998
10
0.020
Why?
Cytotoxicity Tests, Immunologic
1
1998
31
0.020
Why?
Sequence Analysis
1
1998
26
0.020
Why?
Substance Abuse, Intravenous
1
1998
10
0.020
Why?
Histoplasma
1
1997
2
0.020
Why?
Antigens, CD4
1
1998
36
0.020
Why?
Polysaccharides
1
1997
43
0.020
Why?
Culture Media
1
1998
190
0.020
Why?
Antigens, Fungal
1
1997
35
0.020
Why?
Proviruses
1
1997
9
0.020
Why?
Lymphocyte Count
1
1997
52
0.020
Why?
Virus Cultivation
1
1996
30
0.020
Why?
Recurrence
1
1997
656
0.020
Why?
Incidence
1
1998
644
0.020
Why?
Survival Analysis
1
1997
575
0.020
Why?
Longitudinal Studies
1
1997
372
0.020
Why?
Phenotype
1
1998
727
0.020
Why?
Reference Values
1
1996
427
0.020
Why?
Insurance, Life
1
1994
2
0.020
Why?
Infant, Newborn
1
1999
1772
0.010
Why?
Polymerase Chain Reaction
1
1997
586
0.010
Why?
Risk Factors
1
2001
2172
0.010
Why?
Antibodies, Antinuclear
1
1993
30
0.010
Why?
Glycosylation
1
1993
61
0.010
Why?
Vero Cells
1
1993
50
0.010
Why?
Questionnaires
1
1998
942
0.010
Why?
Antigens, CD8
1
1993
30
0.010
Why?
HIV Envelope Protein gp41
1
1993
4
0.010
Why?
Liver
1
1997
870
0.010
Why?
Binding, Competitive
1
1993
201
0.010
Why?
Random Allocation
1
1989
245
0.010
Why?
Retrospective Studies
1
1994
2167
0.010
Why?
Influenza A virus
1
1989
222
0.010
Why?
Histocytochemistry
1
1986
123
0.010
Why?
Molecular Weight
1
1986
348
0.010
Why?
Microscopy, Fluorescence
1
1986
257
0.010
Why?
Antibodies, Monoclonal
1
1986
725
0.010
Why?

Visualizations


Keefer's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department